Looking at cancer health disparities in gynecologic oncology in 2020
- PMID: 34183551
- DOI: 10.1097/GCO.0000000000000713
Looking at cancer health disparities in gynecologic oncology in 2020
Abstract
Purpose of review: To summarize the most recent evidence on gynecologic cancer disparities and to describe studies investigating the social determinants of health and receipt of evidence-based care and potential interventions to address inequities in care.
Recent findings: Significant disparities in disease-specific survival by race/ethnicity, socioeconomic status, and payer status have persisted in women with gynecologic cancers. Compared with white women, black women have an increased likelihood of disease-specific mortality for endometrial cancer and are less likely to receive guideline-adherent care for ovarian cancer. The Covid-19 pandemic has brought significant attention to the structural barriers that contribute to persistent health disparities and how community-based partnerships with a focus on policy interventions are needed for equitable gynecologic cancer outcomes.
Summary: In this review, we discuss structural barriers contributing to racial inequities, the role of Medicaid payer status and receipt of quality cancer care, gender, and racial workforce diversity, and community-based partnerships to create evidence-based interventions to address disparities.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med 2020; 382:2534–2543.
-
- Yancy CW. COVID-19 and African Americans. JAMA 2020; 323:1891–1892.
-
- Farley JH, Hines J, Lee NK, et al. Promoting health equity in the era of COVID-19. Gynecol Oncol 2020; 158:25–31.
-
- Patel MI, Lopez AM, Blackstock W, et al. Cancer disparities and health equity: a policy statement from the American Society of Clinical Oncology. J Clin Oncol 2020; 38:3439–3448.
-
- Awad E, Paladugu R, Jones N, et al. Minority participation in phase 1 gynecologic oncology clinical trials: three decades of inequity. Gynecol Oncol 2020; 157:729–732.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials